Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-19-014149
Filing Date
2019-12-20
Accepted
2019-12-20 18:32:18
Documents
1
Period of Report
2019-12-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 6279
  Complete submission text file 0001654954-19-014149.txt   7623
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Issuer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GEM PHARMACEUTICALS 200 RANDOLPH AVE. HUNTSVILLE AL 35801
Business Address
Leo Karl (Reporting) CIK: 0001727480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39070 | Film No.: 191303093